查找临床试验
已按「胆管癌」检索，对应国际通用词 cholangiocarcinoma
共找到 136 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 00:19，每 5 分钟自动同步A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
United States、Australia、Canada、France、Germany 等 12 国
年龄 8 Years – 不限
Fore Biotherapeutics
A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
United States、France、South Korea、Spain、United Kingdom
年龄 18 Years – 不限
Elevar Therapeutics
LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA)
Italy
年龄 18 Years – 70 Years
Azienda Sanitaria Ospedaliera
Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma
France
年龄 18 Years – 不限
University Hospital, Montpellier
Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
United States
年龄 18 Years – 99 Years
Michael J Cavnar, MD
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
United States、China、Germany、Japan、Netherlands
年龄 18 Years – 不限
Eli Lilly and Company
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
United States
年龄 18 Years – 不限
Stanford University
Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
France
年龄 18 Years – 不限
Assistance Publique - Hôpitaux de Paris
Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)
Netherlands
年龄 18 Years – 不限
Erasmus Medical Center
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
United States、Puerto Rico
年龄 18 Years – 不限
Genfit
A Study of MGC028 in Participants With Advanced Solid Tumors
United States
年龄 18 Years – 不限
MacroGenics
Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion
United States
年龄 18 Years – 不限
M.D. Anderson Cancer Center